- Home
- PNRG vs OBIO Comparison
PNRG vs OBIO Comparison
Compare PNRG & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNRG
- OBIO
- Stock Information
- Founded
- PNRG 1973
- OBIO 2017
- Country
- PNRG United States
- OBIO United States
- Employees
- PNRG N/A
- OBIO N/A
- Industry
- PNRG Oil & Gas Production
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- PNRG Energy
- OBIO Health Care
- Exchange
- PNRG Nasdaq
- OBIO Nasdaq
- Market Cap
- PNRG 207.8M
- OBIO 200.1M
- IPO Year
- PNRG N/A
- OBIO N/A
- Fundamental
- Price
- PNRG $200.00
- OBIO $5.84
- Analyst Decision
- PNRG
- OBIO Strong Buy
- Analyst Count
- PNRG 0
- OBIO 4
- Target Price
- PNRG N/A
- OBIO $15.75
- AVG Volume (30 Days)
- PNRG 4.6K
- OBIO 57.1K
- Earning Date
- PNRG 11-26-2024
- OBIO 11-12-2024
- Dividend Yield
- PNRG N/A
- OBIO N/A
- EPS Growth
- PNRG 71.12
- OBIO N/A
- EPS
- PNRG 23.14
- OBIO N/A
- Revenue
- PNRG $210,064,000.00
- OBIO $2,647,000.00
- Revenue This Year
- PNRG N/A
- OBIO $7.68
- Revenue Next Year
- PNRG N/A
- OBIO $110.40
- P/E Ratio
- PNRG $8.72
- OBIO N/A
- Revenue Growth
- PNRG 88.03
- OBIO N/A
- 52 Week Low
- PNRG $92.40
- OBIO $4.22
- 52 Week High
- PNRG $203.03
- OBIO $11.69
- Technical
- Relative Strength Index (RSI)
- PNRG 71.51
- OBIO 51.19
- Support Level
- PNRG $175.39
- OBIO $5.56
- Resistance Level
- PNRG $188.78
- OBIO $6.50
- Average True Range (ATR)
- PNRG 5.25
- OBIO 0.53
- MACD
- PNRG 1.54
- OBIO 0.00
- Stochastic Oscillator
- PNRG 92.96
- OBIO 56.58
About PNRG PrimeEnergy Resources Corporation
PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and provide well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.